1. Home
  2. PAYO vs PTGX Comparison

PAYO vs PTGX Comparison

Compare PAYO & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Payoneer Global Inc.

PAYO

Payoneer Global Inc.

HOLD

Current Price

$4.79

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$98.97

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYO
PTGX
Founded
2005
2006
Country
United States
United States
Employees
2540
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
5.2B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
PAYO
PTGX
Price
$4.79
$98.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
12
Target Price
$7.69
$106.67
AVG Volume (30 Days)
4.1M
811.3K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.91
$867.86
Revenue Next Year
$9.77
N/A
P/E Ratio
$30.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$39.60
52 Week High
$7.67
$105.69

Technical Indicators

Market Signals
Indicator
PAYO
PTGX
Relative Strength Index (RSI) 47.31 56.73
Support Level $4.32 $76.63
Resistance Level $4.86 $100.00
Average True Range (ATR) 0.20 4.71
MACD 0.07 0.12
Stochastic Oscillator 59.33 53.74

Price Performance

Historical Comparison
PAYO
PTGX

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: